Clinical Trials Logo

Clinical Trial Summary

The objective of the METINFO study is an observational single-center retrospective and descriptive study. The main objective is to estimate the real mortality rate associated to a Metformin overdose. Second objectives are to estimate the real hospitalization rate related to metformin overdose and to identify the risk factors of a metformin overdose and especially the potential correlation between metformin blood concentration and overdose severity.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04762966
Study type Observational
Source Central Hospital, Nancy, France
Contact
Status Recruiting
Phase
Start date March 1, 2021
Completion date September 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04766008 - Metformin in Diabetic Patients Undergoing Coronary Angiography Phase 4